Search Orphan Drug Designations and Approvals
-
Generic Name: | interleukin-1 receptor antagonist anakinra |
---|---|
Date Designated: | 09/15/2015 |
Orphan Designation: | Treatment of Still's disease including systemic juvenile idiopathic arithritis and adult-onset Still's disease. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Swedish Orphan Biovitrum AB SE-112 75 Stockholm Stockholm Sweden The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-